Companies › Xenoport

Xenoport

Healthcare 📍 Santa Clara, United States 👥 11-50 employees 💰 $100.9M raised 📅 Founded 1999

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Total Raised · Venture
$100.9M
Founded
1999
Cloud
Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
Workspace🔒 Subscribers only
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Xenoport's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction